Kymera Therapeutics is a clinical-stage biopharmaceutical company headquartered at 500 North Beacon Street in Watertown, Massachusetts, pioneering targeted protein degradation as a way to build oral small-molecule medicines against targets that conventional inhibitors cannot reach. - View it on GitHub